REGENXBIO Inc. (RGNX) [Rocket]

In millions, except per share items	Jun-30-23	Jun-05-23	Mar-31-23	Dec-31-22	Dec-05-22	Sep-05-22	Jun-30-22	Jun-05-22
	10-Q	8-K	10-Q	10-K	8-K	8-K	10-Q	8-K
Total revenues				112.7			488.5
Revenue growth				-76.3%			187.3%
Cost of goods sold				54.5			65.8
Gross profit				58.2			422.7
Gross margin				51.6%			86.5%
Selling, general and administrative [+]				258.2			249.1
Sales and marketing							84.1
General and administrative				213.8
Other selling, general and administrative				44.4
Other operating expenses				33.1			38.8
EBITDA [+]				-278.3			94.8
EBITDA growth				-287.9%			-183.0%
EBITDA margin				-246.9%			19.4%
Depreciation and amortization				18.1			7.8
EBIT [+]				-296.4			87.0
EBIT growth				-309.7%			-170.9%
EBIT margin				-262.9%			17.8%
Interest expense, net [+]				23.0			-1.9
Interest expense				24.9			13.0
Interest income							1.9
Other income (expense), net [+]				39.0			28.2
Other				-0.5
Pre-tax income				-280.4			104.1
Income taxes				-0.1			13.4
Tax rate				0.0%			12.8%
Net income				-280.3			90.7
Net margin				-248.7%			18.6%

Basic EPS [+]				($6.50)			$2.12
Growth				-315.4%			-158.0%
Diluted EPS [+]				($6.50)			$2.10
Growth				-317.3%			-158.1%

Shares outstanding (basic) [+]				43.1			42.8
Growth				1.8%			7.7%
Shares outstanding (diluted) [+]				43.1			43.1
Growth				0.9%			7.5%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.